Cannara Biotech Inc. (TSXV:LOVE)
Canada · Delayed Price · Currency is CAD 1.830
0.00 (0.00%)
At close: Jan 9, 2026
Cannara Biotech Market Cap
Cannara Biotech has a market cap or net worth of CAD 175.25 million as of January 9, 2026. Its market cap has increased by 170.40% in one year.
Market Cap
175.25M
Enterprise Value
202.47M
Revenue
107.20M
Ranking
n/a
PE Ratio
13.07
Stock Price
1.83
Market Cap Chart
Since January 14, 2019, Cannara Biotech's market cap has decreased from 211.62M to 175.25M, a decrease of -17.18%. That is a compound annual growth rate of -2.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 175.25M | 6.04% |
| Dec 31, 2025 | 165.28M | 148.11% |
| Dec 31, 2024 | 66.61M | -10.84% |
| Dec 29, 2023 | 74.72M | -10.37% |
| Dec 30, 2022 | 83.36M | -29.55% |
| Dec 31, 2021 | 118.32M | 100.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 2.70B |
| Green Thumb Industries | 2.61B |
| dentalcorp Holdings | 2.19B |
| Extendicare | 2.07B |
| Trulieve Cannabis | 2.05B |
| Sienna Senior Living | 2.00B |
| Cronos Group | 1.43B |
| WELL Health Technologies | 1.07B |